Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

06/04/2020, Thursday


Media Contacts:
Sam Ewing
sam.ewing@zenogroup.com
(917) 415-3842
 

FDA PROVIDES 510(k) CLEARANCE FOR BAUSCH + LOMB INFUSE™ DAILY DISPOSABLE SILICONE HYDROGEL (SiHy DAILY) CONTACT LENSES


BRIDGEWATER, N.J., June 4, 2020 – Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for BAUSCH + LOMB INFUSE™ daily disposable silicone hydrogel (SiHy daily) contact lenses.

BAUSCH + LOMB INFUSE contact lenses feature a next generation contact lens material (kalifilcon A), which is designed to meet the unmet needs of contact lens wearers, including those who experience contact lens dryness. Engineered with Bausch + Lomb’s most advanced proprietary contact lens technologies, BAUSCH + LOMB INFUSE offers outstanding breathability for healthy lens wear while providing exceptional all-day comfort and high definition optics.

“The FDA 510(k) clearance of BAUSCH + LOMB INFUSE SiHy daily contact lens represents a unique opportunity for our customers to address the significant unmet need related to contact lens dryness, the number one ocular symptom for daily disposable lens wearers,” said John Ferris, vice president and general manager, Vision Care, Bausch + Lomb. “We’re excited to share our continued innovation in providing new options for vision care that are also mindful of the health and comfort our customers require for a better wearing experience.”

About Bausch + Lomb
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.

Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch Health’s most recent annual report on Form 10-K and detailed from time to time in Bausch Health’s other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on Bausch Health, including but not limited to its project development timelines, and costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

###

®/TM are trademarks of Bausch & Lomb Incorporated or its affiliates.
© 2020 Bausch + Lomb Incorporated or its affiliates.
INF.0044.USA.20

Print

Number of views (2435)/Comments (0)

x